Agios Pharmaceuticals (AGIO) Operating Income Growth (3y) (2015 - 2026)
Agios Pharmaceuticals (AGIO) Operating Income Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.21 Bn | 1.47 Bn | 19.43 Mn | -6.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.68% |
| Dec 31, 2025 | -7.03% |
| Sep 30, 2025 | -8.66% |
| Jun 30, 2025 | -9.17% |
| Mar 31, 2025 | -1.78% |
| Dec 31, 2024 | -6.05% |
| Sep 30, 2024 | -4.09% |
| Jun 30, 2024 | -5.07% |
| Mar 31, 2024 | -0.31% |
| Dec 31, 2023 | -4.76% |
| Sep 30, 2023 | -7.91% |
| Jun 30, 2023 | -4.01% |
| Mar 31, 2023 | -1.35% |
| Dec 31, 2022 | 2.17% |
| Sep 30, 2022 | 5.83% |
| Jun 30, 2022 | 4.99% |
| Mar 31, 2022 | -1.24% |
| Dec 31, 2021 | -2.85% |
| Sep 30, 2021 | 2.77% |
| Jun 30, 2021 | -7.74% |